Lyrica is one of 58 small molecule programs targeting Epilepsy. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
84 competitors in Epilepsy
Tegretol
Vimpat
Trileptal
Fycompa
Lexapro
Diamox
Briviact
Dilantin
Ketalar
Neurontin
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details